Regular Reports-Consun Pharmaceutical Group

Home
Approach To Consun
Company profile Management team Business Structure
Product Center
Products Introduction Product video Nephrology series Imaging Series Women & Children Series Orthopedics Series Dermatology Series Hepatobiliary Series Gastroenterology Series Tonic Series Other Products
R&D Innovation
R&D Platform R&D Team R&D Technology R&D Achievements
Investor Relations
Corporate Governance Announcements & Circulars Regular Reports Documents available for inspection IR Contact

中文

Investor Relations

Corporate Governance
Announcements & Circulars
Regular Reports
Documents available for inspection
IR Contact

Regular Reports

2025-09-19 INTERIM REPORT 2025
2025-04-28 2024 Environmental, Social and Governance Report
2025-04-28 ANNUAL REPORT 2024
2024-09-27 INTERIM REPORT 2024
2024-04-30 2023 Environmental, Social and Governance Report
2024-04-30 ANNUAL REPORT 2023
2023-09-27 INTERIM REPORT 2023
2023-04-28 2022 Environmental, Social and Governance Report
2023-04-28 ANNUAL REPORT 2022
2022-09-23 INTERIM REPORT 2022

HomePrevious12 3 4 Next Last

Approach To Consun
Product Center
R&D Innovation
Investor Relations

400-930-1681

总机：（86）20-82016888

service@chinaconsun.com

71 Dongpeng Avenue, Huangpu District, Guangzhou

Consun
Health Station
Micro mall

工商红盾标志

Friendship Link: State Food and Drug Administration Inner Mongolia Food and Drug Administration Guangdong Food and Drug Administration Guangxi Food and Drug Administration

粤ICP备15001491号 Design: uweb